课题基金 / 基金详情

Application of plasma proteins as blood substitutes

Application of plasma proteins as blood substitutes
血浆蛋白作为血液代用品的应用
批准号:
11794016
负责人:
NISHI Katsuhide
金额:
$16.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for University and Society Collaboration
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

NISHI Katsuhide的其他基金

相似基金

相关文献

中文摘要
翻译
Nishi等人。研究了吡哆醇糖化血红蛋白聚氧乙烯醚结合物对肠蠕动的抑制作用、α_1-酸性糖蛋白(α_1-AGP)促进红细胞通过微孔滤器的作用以及α_1-AGP对主动脉血管的扩张作用。发现生理条件下发生的α_1-蛋白酶抑制剂S亚硝化(α_1-PI)对α_1-PI的细胞保护作用的生物学功能存在差异,提示S亚硝化的α_1-AGP可能具有多种生物学功能。纯化的重组人血清白蛋白(RHSA),由毕赤酵母表达系统分泌,具有与从血清中分离的HSA非常相似的结构特征、稳定性和配体结合特性。分析了来自大肠杆菌的四螺旋束血红素蛋白细胞色素b562结构中辅因子周围的氨基酸残基,并开发了一种在该蛋白中设计外源配体结合口袋的策略。
英文摘要
Nishi et al. found the inhibitory effects of pyridoxalated hemoglobin polyoxyethylene conjugate (PHP) on the intestinal peristaltic movement, the facilitatory effect of α_1-acid glycoprotein (α_1-AGP) on the passage of red blood cells through filters with micropores, and the vasodilator action of α_1-AGP in aorta.Maeda et al. found that S-nitrosylation of α_1-protease inhibitor (α_1-PI) occurring under physiological conditions should diverse in the biological functions contributing to cytoprotective effects of α_1-PI, and suggested that S-nitrosylated α_1-AGP would have the multiple biological functions.Otagiri et al. purified recombinant human serum albumin (rHSA), secreted by a Pichia pastoris expression system, and showed very similar structural characteristics, stability and ligand-binding properties of the rHSA as HSA isolated from sera.Uno et al. analyzed the amino acid residues surrounding the cofactor in the structures of a four-helix bundle heme protein, cytochrome b562 from E. coli, and developed a strategy for designing an exogenous ligand binding pocket into this protein.
期刊论文(97)
专著(0)
科研奖励(0)
会议论文
K.Yamasaki, H.M.Rahman, M.Otagiri, et al.: "Circular Dichroism Simulation shows a Site-II-Site-I Displacement of Human Serum Albumin-bound Diclofenac by Ibuprofen"AAPS Pharm.Sci.Tech.. 1(2). article 12 (2000)
K.Yamasaki、H.M.Rahman、M.Otagiri 等人:“圆二色性模拟显示布洛芬对人血清白蛋白结合的双氯芬酸进行位点 II-位点 I 置换”AAPS Pharm.Sci.Tech.. 1(2
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Tsutsumi, T.Maruyama, M.Otagiri, et al.: "Decreased Bilirubin-binding Capacity in Uremic Serum Caused by an Acumulation of Furan Dicarboxylic Acid"Nephron. 85(1). 60-64 (2000)
Y.Tsutsumi、T.Maruyama、M.Otagiri 等人:“呋喃二羧酸积聚导致尿毒症血清胆红素结合能力降低”肾单位。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tokutomi, Y., Tokutomi, N., Nishi K.: "The properties of ryanodine-sensitive Ca^<2+> release in mouse gastric smooth muscle cells"British Journal of Pharmacology. 133. 125-137 (2001)
Tokutomi,Y.,Tokutomi,N.,Nishi K.:“小鼠胃平滑肌细胞中兰尼碱敏感的Ca ^ 2 释放的特性”英国药理学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
J.Wu, T.Akaike, K.Hayashida, T.Okamoto, A.Okuyama: "Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinase"Jpn.J.Cancer Res.. 92. 439-451 (2001)
J.Wu、T.Akaike、K.Hayashida、T.Okamoto、A.Okuyama:“涉及过氧亚硝酸盐和基质金属蛋白酶的实体瘤中血管通透性增强”Jpn.J.Cancer Res.. 92. 439-451 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 85 条
    Roles of Kit signalling in smooth muscle tissues
    • 批准号:
      13470020
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.04万
    • 财政年份:
      2001
    • 负责人:
      NISHI Katsuhide
    • 依托单位:
    Molecular mechanism of development of mammalian smooth mscle
    • 批准号:
      10470025
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.45万
    • 财政年份:
      1998
    • 负责人:
      NISHI Katsuhide
    • 依托单位:
    Molecular basis for occurence of the spontaneous activity of smooth muscle-consisting organs, and its functinal disorder.
    • 批准号:
      08307020
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $5.7万
    • 财政年份:
      1996
    • 负责人:
      NISHI Katsuhide
    • 依托单位:
    A Role of c-kit tyrosinekinase of physiological development of the gastrointestinal pacemaker activity
    • 批准号:
      06454163
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.54万
    • 财政年份:
      1994
    • 负责人:
      NISHI Katsuhide
    • 依托单位:
    海外基金